, Volume 57, Issue 3, pp 285-288,
Open Access This content is freely available online to anyone, anywhere at any time.
Date: 25 Aug 2007

Toward the harmonization of immune monitoring in clinical trials: Quo vadis?

C. M. Britten and S. Janetzki both authors contributed equally to this work.
This commentary refers to the two original articles “The CIMT-Monitoring panel: A two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays” by C. M. Britten et al. and “Results and Harmonization Guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)” by S. Janetzki et al.